Global Injectable Viscosupplementation for Joint Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
LPI (LP Information)' newest research report, the “Injectable Viscosupplementation for Joint Industry Forecast” looks at past sales and reviews total world Injectable Viscosupplementation for Joint sales in 2022, providing a comprehensive analysis by region and market sector of projected Injectable Viscosupplementation for Joint sales for 2023 through 2029. With Injectable Viscosupplementation for Joint sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Viscosupplementation for Joint industry.
This Insight Report provides a comprehensive analysis of the global Injectable Viscosupplementation for Joint landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable Viscosupplementation for Joint portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Injectable Viscosupplementation for Joint market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Viscosupplementation for Joint and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Viscosupplementation for Joint.
The global Injectable Viscosupplementation for Joint market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Injectable Viscosupplementation for Joint is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Injectable Viscosupplementation for Joint is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Injectable Viscosupplementation for Joint is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Injectable Viscosupplementation for Joint players cover Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Viscosupplementation for Joint market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Injectable Viscosupplementation for Joint market?
What factors are driving Injectable Viscosupplementation for Joint market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Injectable Viscosupplementation for Joint market opportunities vary by end market size?
How does Injectable Viscosupplementation for Joint break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
LPI (LP Information)' newest research report, the “Injectable Viscosupplementation for Joint Industry Forecast” looks at past sales and reviews total world Injectable Viscosupplementation for Joint sales in 2022, providing a comprehensive analysis by region and market sector of projected Injectable Viscosupplementation for Joint sales for 2023 through 2029. With Injectable Viscosupplementation for Joint sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Viscosupplementation for Joint industry.
This Insight Report provides a comprehensive analysis of the global Injectable Viscosupplementation for Joint landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable Viscosupplementation for Joint portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Injectable Viscosupplementation for Joint market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Viscosupplementation for Joint and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Viscosupplementation for Joint.
The global Injectable Viscosupplementation for Joint market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Injectable Viscosupplementation for Joint is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Injectable Viscosupplementation for Joint is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Injectable Viscosupplementation for Joint is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Injectable Viscosupplementation for Joint players cover Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Viscosupplementation for Joint market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Single Injection
- Three Injection
- Five Injection
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Anika Therapeutics
- Seikagaku
- Zimmer Biomet
- Bioventus
- Ferring
- LG Chem
- Freda
- Haohai Biological
- Shanghai Jingfeng
What is the 10-year outlook for the global Injectable Viscosupplementation for Joint market?
What factors are driving Injectable Viscosupplementation for Joint market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Injectable Viscosupplementation for Joint market opportunities vary by end market size?
How does Injectable Viscosupplementation for Joint break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injectable Viscosupplementation for Joint Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Injectable Viscosupplementation for Joint by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Injectable Viscosupplementation for Joint by Country/Region, 2018, 2022 & 2029
2.2 Injectable Viscosupplementation for Joint Segment by Type
2.2.1 Single Injection
2.2.2 Three Injection
2.2.3 Five Injection
2.3 Injectable Viscosupplementation for Joint Sales by Type
2.3.1 Global Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
2.3.2 Global Injectable Viscosupplementation for Joint Revenue and Market Share by Type (2018-2023)
2.3.3 Global Injectable Viscosupplementation for Joint Sale Price by Type (2018-2023)
2.4 Injectable Viscosupplementation for Joint Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Injectable Viscosupplementation for Joint Sales by Application
2.5.1 Global Injectable Viscosupplementation for Joint Sale Market Share by Application (2018-2023)
2.5.2 Global Injectable Viscosupplementation for Joint Revenue and Market Share by Application (2018-2023)
2.5.3 Global Injectable Viscosupplementation for Joint Sale Price by Application (2018-2023)
3 GLOBAL INJECTABLE VISCOSUPPLEMENTATION FOR JOINT BY COMPANY
3.1 Global Injectable Viscosupplementation for Joint Breakdown Data by Company
3.1.1 Global Injectable Viscosupplementation for Joint Annual Sales by Company (2018-2023)
3.1.2 Global Injectable Viscosupplementation for Joint Sales Market Share by Company (2018-2023)
3.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Company (2018-2023)
3.2.1 Global Injectable Viscosupplementation for Joint Revenue by Company (2018-2023)
3.2.2 Global Injectable Viscosupplementation for Joint Revenue Market Share by Company (2018-2023)
3.3 Global Injectable Viscosupplementation for Joint Sale Price by Company
3.4 Key Manufacturers Injectable Viscosupplementation for Joint Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable Viscosupplementation for Joint Product Location Distribution
3.4.2 Players Injectable Viscosupplementation for Joint Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INJECTABLE VISCOSUPPLEMENTATION FOR JOINT BY GEOGRAPHIC REGION
4.1 World Historic Injectable Viscosupplementation for Joint Market Size by Geographic Region (2018-2023)
4.1.1 Global Injectable Viscosupplementation for Joint Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Injectable Viscosupplementation for Joint Market Size by Country/Region (2018-2023)
4.2.1 Global Injectable Viscosupplementation for Joint Annual Sales by Country/Region (2018-2023)
4.2.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Country/Region (2018-2023)
4.3 Americas Injectable Viscosupplementation for Joint Sales Growth
4.4 APAC Injectable Viscosupplementation for Joint Sales Growth
4.5 Europe Injectable Viscosupplementation for Joint Sales Growth
4.6 Middle East & Africa Injectable Viscosupplementation for Joint Sales Growth
5 AMERICAS
5.1 Americas Injectable Viscosupplementation for Joint Sales by Country
5.1.1 Americas Injectable Viscosupplementation for Joint Sales by Country (2018-2023)
5.1.2 Americas Injectable Viscosupplementation for Joint Revenue by Country (2018-2023)
5.2 Americas Injectable Viscosupplementation for Joint Sales by Type
5.3 Americas Injectable Viscosupplementation for Joint Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable Viscosupplementation for Joint Sales by Region
6.1.1 APAC Injectable Viscosupplementation for Joint Sales by Region (2018-2023)
6.1.2 APAC Injectable Viscosupplementation for Joint Revenue by Region (2018-2023)
6.2 APAC Injectable Viscosupplementation for Joint Sales by Type
6.3 APAC Injectable Viscosupplementation for Joint Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injectable Viscosupplementation for Joint by Country
7.1.1 Europe Injectable Viscosupplementation for Joint Sales by Country (2018-2023)
7.1.2 Europe Injectable Viscosupplementation for Joint Revenue by Country (2018-2023)
7.2 Europe Injectable Viscosupplementation for Joint Sales by Type
7.3 Europe Injectable Viscosupplementation for Joint Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injectable Viscosupplementation for Joint by Country
8.1.1 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Country (2018-2023)
8.1.2 Middle East & Africa Injectable Viscosupplementation for Joint Revenue by Country (2018-2023)
8.2 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Type
8.3 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable Viscosupplementation for Joint
10.3 Manufacturing Process Analysis of Injectable Viscosupplementation for Joint
10.4 Industry Chain Structure of Injectable Viscosupplementation for Joint
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable Viscosupplementation for Joint Distributors
11.3 Injectable Viscosupplementation for Joint Customer
12 WORLD FORECAST REVIEW FOR INJECTABLE VISCOSUPPLEMENTATION FOR JOINT BY GEOGRAPHIC REGION
12.1 Global Injectable Viscosupplementation for Joint Market Size Forecast by Region
12.1.1 Global Injectable Viscosupplementation for Joint Forecast by Region (2024-2029)
12.1.2 Global Injectable Viscosupplementation for Joint Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injectable Viscosupplementation for Joint Forecast by Type
12.7 Global Injectable Viscosupplementation for Joint Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.1.3 Sanofi Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Anika Therapeutics
13.2.1 Anika Therapeutics Company Information
13.2.2 Anika Therapeutics Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Anika Therapeutics Main Business Overview
13.2.5 Anika Therapeutics Latest Developments
13.3 Seikagaku
13.3.1 Seikagaku Company Information
13.3.2 Seikagaku Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.3.3 Seikagaku Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Seikagaku Main Business Overview
13.3.5 Seikagaku Latest Developments
13.4 Zimmer Biomet
13.4.1 Zimmer Biomet Company Information
13.4.2 Zimmer Biomet Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zimmer Biomet Main Business Overview
13.4.5 Zimmer Biomet Latest Developments
13.5 Bioventus
13.5.1 Bioventus Company Information
13.5.2 Bioventus Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.5.3 Bioventus Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bioventus Main Business Overview
13.5.5 Bioventus Latest Developments
13.6 Ferring
13.6.1 Ferring Company Information
13.6.2 Ferring Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.6.3 Ferring Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ferring Main Business Overview
13.6.5 Ferring Latest Developments
13.7 LG Chem
13.7.1 LG Chem Company Information
13.7.2 LG Chem Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.7.3 LG Chem Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 LG Chem Main Business Overview
13.7.5 LG Chem Latest Developments
13.8 Freda
13.8.1 Freda Company Information
13.8.2 Freda Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.8.3 Freda Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Freda Main Business Overview
13.8.5 Freda Latest Developments
13.9 Haohai Biological
13.9.1 Haohai Biological Company Information
13.9.2 Haohai Biological Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.9.3 Haohai Biological Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Haohai Biological Main Business Overview
13.9.5 Haohai Biological Latest Developments
13.10 Shanghai Jingfeng
13.10.1 Shanghai Jingfeng Company Information
13.10.2 Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai Jingfeng Main Business Overview
13.10.5 Shanghai Jingfeng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injectable Viscosupplementation for Joint Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Injectable Viscosupplementation for Joint by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Injectable Viscosupplementation for Joint by Country/Region, 2018, 2022 & 2029
2.2 Injectable Viscosupplementation for Joint Segment by Type
2.2.1 Single Injection
2.2.2 Three Injection
2.2.3 Five Injection
2.3 Injectable Viscosupplementation for Joint Sales by Type
2.3.1 Global Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
2.3.2 Global Injectable Viscosupplementation for Joint Revenue and Market Share by Type (2018-2023)
2.3.3 Global Injectable Viscosupplementation for Joint Sale Price by Type (2018-2023)
2.4 Injectable Viscosupplementation for Joint Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Injectable Viscosupplementation for Joint Sales by Application
2.5.1 Global Injectable Viscosupplementation for Joint Sale Market Share by Application (2018-2023)
2.5.2 Global Injectable Viscosupplementation for Joint Revenue and Market Share by Application (2018-2023)
2.5.3 Global Injectable Viscosupplementation for Joint Sale Price by Application (2018-2023)
3 GLOBAL INJECTABLE VISCOSUPPLEMENTATION FOR JOINT BY COMPANY
3.1 Global Injectable Viscosupplementation for Joint Breakdown Data by Company
3.1.1 Global Injectable Viscosupplementation for Joint Annual Sales by Company (2018-2023)
3.1.2 Global Injectable Viscosupplementation for Joint Sales Market Share by Company (2018-2023)
3.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Company (2018-2023)
3.2.1 Global Injectable Viscosupplementation for Joint Revenue by Company (2018-2023)
3.2.2 Global Injectable Viscosupplementation for Joint Revenue Market Share by Company (2018-2023)
3.3 Global Injectable Viscosupplementation for Joint Sale Price by Company
3.4 Key Manufacturers Injectable Viscosupplementation for Joint Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable Viscosupplementation for Joint Product Location Distribution
3.4.2 Players Injectable Viscosupplementation for Joint Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INJECTABLE VISCOSUPPLEMENTATION FOR JOINT BY GEOGRAPHIC REGION
4.1 World Historic Injectable Viscosupplementation for Joint Market Size by Geographic Region (2018-2023)
4.1.1 Global Injectable Viscosupplementation for Joint Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Injectable Viscosupplementation for Joint Market Size by Country/Region (2018-2023)
4.2.1 Global Injectable Viscosupplementation for Joint Annual Sales by Country/Region (2018-2023)
4.2.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Country/Region (2018-2023)
4.3 Americas Injectable Viscosupplementation for Joint Sales Growth
4.4 APAC Injectable Viscosupplementation for Joint Sales Growth
4.5 Europe Injectable Viscosupplementation for Joint Sales Growth
4.6 Middle East & Africa Injectable Viscosupplementation for Joint Sales Growth
5 AMERICAS
5.1 Americas Injectable Viscosupplementation for Joint Sales by Country
5.1.1 Americas Injectable Viscosupplementation for Joint Sales by Country (2018-2023)
5.1.2 Americas Injectable Viscosupplementation for Joint Revenue by Country (2018-2023)
5.2 Americas Injectable Viscosupplementation for Joint Sales by Type
5.3 Americas Injectable Viscosupplementation for Joint Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable Viscosupplementation for Joint Sales by Region
6.1.1 APAC Injectable Viscosupplementation for Joint Sales by Region (2018-2023)
6.1.2 APAC Injectable Viscosupplementation for Joint Revenue by Region (2018-2023)
6.2 APAC Injectable Viscosupplementation for Joint Sales by Type
6.3 APAC Injectable Viscosupplementation for Joint Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injectable Viscosupplementation for Joint by Country
7.1.1 Europe Injectable Viscosupplementation for Joint Sales by Country (2018-2023)
7.1.2 Europe Injectable Viscosupplementation for Joint Revenue by Country (2018-2023)
7.2 Europe Injectable Viscosupplementation for Joint Sales by Type
7.3 Europe Injectable Viscosupplementation for Joint Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injectable Viscosupplementation for Joint by Country
8.1.1 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Country (2018-2023)
8.1.2 Middle East & Africa Injectable Viscosupplementation for Joint Revenue by Country (2018-2023)
8.2 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Type
8.3 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable Viscosupplementation for Joint
10.3 Manufacturing Process Analysis of Injectable Viscosupplementation for Joint
10.4 Industry Chain Structure of Injectable Viscosupplementation for Joint
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable Viscosupplementation for Joint Distributors
11.3 Injectable Viscosupplementation for Joint Customer
12 WORLD FORECAST REVIEW FOR INJECTABLE VISCOSUPPLEMENTATION FOR JOINT BY GEOGRAPHIC REGION
12.1 Global Injectable Viscosupplementation for Joint Market Size Forecast by Region
12.1.1 Global Injectable Viscosupplementation for Joint Forecast by Region (2024-2029)
12.1.2 Global Injectable Viscosupplementation for Joint Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injectable Viscosupplementation for Joint Forecast by Type
12.7 Global Injectable Viscosupplementation for Joint Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.1.3 Sanofi Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Anika Therapeutics
13.2.1 Anika Therapeutics Company Information
13.2.2 Anika Therapeutics Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Anika Therapeutics Main Business Overview
13.2.5 Anika Therapeutics Latest Developments
13.3 Seikagaku
13.3.1 Seikagaku Company Information
13.3.2 Seikagaku Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.3.3 Seikagaku Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Seikagaku Main Business Overview
13.3.5 Seikagaku Latest Developments
13.4 Zimmer Biomet
13.4.1 Zimmer Biomet Company Information
13.4.2 Zimmer Biomet Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zimmer Biomet Main Business Overview
13.4.5 Zimmer Biomet Latest Developments
13.5 Bioventus
13.5.1 Bioventus Company Information
13.5.2 Bioventus Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.5.3 Bioventus Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bioventus Main Business Overview
13.5.5 Bioventus Latest Developments
13.6 Ferring
13.6.1 Ferring Company Information
13.6.2 Ferring Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.6.3 Ferring Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ferring Main Business Overview
13.6.5 Ferring Latest Developments
13.7 LG Chem
13.7.1 LG Chem Company Information
13.7.2 LG Chem Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.7.3 LG Chem Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 LG Chem Main Business Overview
13.7.5 LG Chem Latest Developments
13.8 Freda
13.8.1 Freda Company Information
13.8.2 Freda Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.8.3 Freda Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Freda Main Business Overview
13.8.5 Freda Latest Developments
13.9 Haohai Biological
13.9.1 Haohai Biological Company Information
13.9.2 Haohai Biological Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.9.3 Haohai Biological Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Haohai Biological Main Business Overview
13.9.5 Haohai Biological Latest Developments
13.10 Shanghai Jingfeng
13.10.1 Shanghai Jingfeng Company Information
13.10.2 Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Portfolios and Specifications
13.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai Jingfeng Main Business Overview
13.10.5 Shanghai Jingfeng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Injectable Viscosupplementation for Joint Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Injectable Viscosupplementation for Joint Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Injection
Table 4. Major Players of Three Injection
Table 5. Major Players of Five Injection
Table 6. Global Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 7. Global Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Table 8. Global Injectable Viscosupplementation for Joint Revenue by Type (2018-2023) & ($ million)
Table 9. Global Injectable Viscosupplementation for Joint Revenue Market Share by Type (2018-2023)
Table 10. Global Injectable Viscosupplementation for Joint Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 12. Global Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Table 13. Global Injectable Viscosupplementation for Joint Revenue by Application (2018-2023)
Table 14. Global Injectable Viscosupplementation for Joint Revenue Market Share by Application (2018-2023)
Table 15. Global Injectable Viscosupplementation for Joint Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Injectable Viscosupplementation for Joint Sales by Company (2018-2023) & (Units)
Table 17. Global Injectable Viscosupplementation for Joint Sales Market Share by Company (2018-2023)
Table 18. Global Injectable Viscosupplementation for Joint Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Injectable Viscosupplementation for Joint Revenue Market Share by Company (2018-2023)
Table 20. Global Injectable Viscosupplementation for Joint Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Injectable Viscosupplementation for Joint Producing Area Distribution and Sales Area
Table 22. Players Injectable Viscosupplementation for Joint Products Offered
Table 23. Injectable Viscosupplementation for Joint Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Injectable Viscosupplementation for Joint Sales by Geographic Region (2018-2023) & (Units)
Table 27. Global Injectable Viscosupplementation for Joint Sales Market Share Geographic Region (2018-2023)
Table 28. Global Injectable Viscosupplementation for Joint Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Injectable Viscosupplementation for Joint Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Injectable Viscosupplementation for Joint Sales by Country/Region (2018-2023) & (Units)
Table 31. Global Injectable Viscosupplementation for Joint Sales Market Share by Country/Region (2018-2023)
Table 32. Global Injectable Viscosupplementation for Joint Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Injectable Viscosupplementation for Joint Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Injectable Viscosupplementation for Joint Sales by Country (2018-2023) & (Units)
Table 35. Americas Injectable Viscosupplementation for Joint Sales Market Share by Country (2018-2023)
Table 36. Americas Injectable Viscosupplementation for Joint Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Injectable Viscosupplementation for Joint Revenue Market Share by Country (2018-2023)
Table 38. Americas Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 39. Americas Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 40. APAC Injectable Viscosupplementation for Joint Sales by Region (2018-2023) & (Units)
Table 41. APAC Injectable Viscosupplementation for Joint Sales Market Share by Region (2018-2023)
Table 42. APAC Injectable Viscosupplementation for Joint Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Injectable Viscosupplementation for Joint Revenue Market Share by Region (2018-2023)
Table 44. APAC Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 45. APAC Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 46. Europe Injectable Viscosupplementation for Joint Sales by Country (2018-2023) & (Units)
Table 47. Europe Injectable Viscosupplementation for Joint Sales Market Share by Country (2018-2023)
Table 48. Europe Injectable Viscosupplementation for Joint Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Injectable Viscosupplementation for Joint Revenue Market Share by Country (2018-2023)
Table 50. Europe Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 51. Europe Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 52. Middle East & Africa Injectable Viscosupplementation for Joint Sales by Country (2018-2023) & (Units)
Table 53. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Injectable Viscosupplementation for Joint Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Injectable Viscosupplementation for Joint Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 57. Middle East & Africa Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 58. Key Market Drivers & Growth Opportunities of Injectable Viscosupplementation for Joint
Table 59. Key Market Challenges & Risks of Injectable Viscosupplementation for Joint
Table 60. Key Industry Trends of Injectable Viscosupplementation for Joint
Table 61. Injectable Viscosupplementation for Joint Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Injectable Viscosupplementation for Joint Distributors List
Table 64. Injectable Viscosupplementation for Joint Customer List
Table 65. Global Injectable Viscosupplementation for Joint Sales Forecast by Region (2024-2029) & (Units)
Table 66. Global Injectable Viscosupplementation for Joint Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Injectable Viscosupplementation for Joint Sales Forecast by Country (2024-2029) & (Units)
Table 68. Americas Injectable Viscosupplementation for Joint Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Injectable Viscosupplementation for Joint Sales Forecast by Region (2024-2029) & (Units)
Table 70. APAC Injectable Viscosupplementation for Joint Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Injectable Viscosupplementation for Joint Sales Forecast by Country (2024-2029) & (Units)
Table 72. Europe Injectable Viscosupplementation for Joint Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Injectable Viscosupplementation for Joint Sales Forecast by Country (2024-2029) & (Units)
Table 74. Middle East & Africa Injectable Viscosupplementation for Joint Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Injectable Viscosupplementation for Joint Sales Forecast by Type (2024-2029) & (Units)
Table 76. Global Injectable Viscosupplementation for Joint Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Injectable Viscosupplementation for Joint Sales Forecast by Application (2024-2029) & (Units)
Table 78. Global Injectable Viscosupplementation for Joint Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Sanofi Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 81. Sanofi Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Anika Therapeutics Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 85. Anika Therapeutics Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 86. Anika Therapeutics Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Anika Therapeutics Main Business
Table 88. Anika Therapeutics Latest Developments
Table 89. Seikagaku Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 90. Seikagaku Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 91. Seikagaku Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Seikagaku Main Business
Table 93. Seikagaku Latest Developments
Table 94. Zimmer Biomet Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 95. Zimmer Biomet Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 96. Zimmer Biomet Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Zimmer Biomet Main Business
Table 98. Zimmer Biomet Latest Developments
Table 99. Bioventus Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 100. Bioventus Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 101. Bioventus Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Bioventus Main Business
Table 103. Bioventus Latest Developments
Table 104. Ferring Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 105. Ferring Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 106. Ferring Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Ferring Main Business
Table 108. Ferring Latest Developments
Table 109. LG Chem Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 110. LG Chem Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 111. LG Chem Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. LG Chem Main Business
Table 113. LG Chem Latest Developments
Table 114. Freda Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 115. Freda Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 116. Freda Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Freda Main Business
Table 118. Freda Latest Developments
Table 119. Haohai Biological Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 120. Haohai Biological Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 121. Haohai Biological Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Haohai Biological Main Business
Table 123. Haohai Biological Latest Developments
Table 124. Shanghai Jingfeng Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 125. Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 126. Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Shanghai Jingfeng Main Business
Table 128. Shanghai Jingfeng Latest Developments
Table 1. Injectable Viscosupplementation for Joint Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Injectable Viscosupplementation for Joint Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Injection
Table 4. Major Players of Three Injection
Table 5. Major Players of Five Injection
Table 6. Global Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 7. Global Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Table 8. Global Injectable Viscosupplementation for Joint Revenue by Type (2018-2023) & ($ million)
Table 9. Global Injectable Viscosupplementation for Joint Revenue Market Share by Type (2018-2023)
Table 10. Global Injectable Viscosupplementation for Joint Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 12. Global Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Table 13. Global Injectable Viscosupplementation for Joint Revenue by Application (2018-2023)
Table 14. Global Injectable Viscosupplementation for Joint Revenue Market Share by Application (2018-2023)
Table 15. Global Injectable Viscosupplementation for Joint Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Injectable Viscosupplementation for Joint Sales by Company (2018-2023) & (Units)
Table 17. Global Injectable Viscosupplementation for Joint Sales Market Share by Company (2018-2023)
Table 18. Global Injectable Viscosupplementation for Joint Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Injectable Viscosupplementation for Joint Revenue Market Share by Company (2018-2023)
Table 20. Global Injectable Viscosupplementation for Joint Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Injectable Viscosupplementation for Joint Producing Area Distribution and Sales Area
Table 22. Players Injectable Viscosupplementation for Joint Products Offered
Table 23. Injectable Viscosupplementation for Joint Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Injectable Viscosupplementation for Joint Sales by Geographic Region (2018-2023) & (Units)
Table 27. Global Injectable Viscosupplementation for Joint Sales Market Share Geographic Region (2018-2023)
Table 28. Global Injectable Viscosupplementation for Joint Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Injectable Viscosupplementation for Joint Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Injectable Viscosupplementation for Joint Sales by Country/Region (2018-2023) & (Units)
Table 31. Global Injectable Viscosupplementation for Joint Sales Market Share by Country/Region (2018-2023)
Table 32. Global Injectable Viscosupplementation for Joint Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Injectable Viscosupplementation for Joint Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Injectable Viscosupplementation for Joint Sales by Country (2018-2023) & (Units)
Table 35. Americas Injectable Viscosupplementation for Joint Sales Market Share by Country (2018-2023)
Table 36. Americas Injectable Viscosupplementation for Joint Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Injectable Viscosupplementation for Joint Revenue Market Share by Country (2018-2023)
Table 38. Americas Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 39. Americas Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 40. APAC Injectable Viscosupplementation for Joint Sales by Region (2018-2023) & (Units)
Table 41. APAC Injectable Viscosupplementation for Joint Sales Market Share by Region (2018-2023)
Table 42. APAC Injectable Viscosupplementation for Joint Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Injectable Viscosupplementation for Joint Revenue Market Share by Region (2018-2023)
Table 44. APAC Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 45. APAC Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 46. Europe Injectable Viscosupplementation for Joint Sales by Country (2018-2023) & (Units)
Table 47. Europe Injectable Viscosupplementation for Joint Sales Market Share by Country (2018-2023)
Table 48. Europe Injectable Viscosupplementation for Joint Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Injectable Viscosupplementation for Joint Revenue Market Share by Country (2018-2023)
Table 50. Europe Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 51. Europe Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 52. Middle East & Africa Injectable Viscosupplementation for Joint Sales by Country (2018-2023) & (Units)
Table 53. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Injectable Viscosupplementation for Joint Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Injectable Viscosupplementation for Joint Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Injectable Viscosupplementation for Joint Sales by Type (2018-2023) & (Units)
Table 57. Middle East & Africa Injectable Viscosupplementation for Joint Sales by Application (2018-2023) & (Units)
Table 58. Key Market Drivers & Growth Opportunities of Injectable Viscosupplementation for Joint
Table 59. Key Market Challenges & Risks of Injectable Viscosupplementation for Joint
Table 60. Key Industry Trends of Injectable Viscosupplementation for Joint
Table 61. Injectable Viscosupplementation for Joint Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Injectable Viscosupplementation for Joint Distributors List
Table 64. Injectable Viscosupplementation for Joint Customer List
Table 65. Global Injectable Viscosupplementation for Joint Sales Forecast by Region (2024-2029) & (Units)
Table 66. Global Injectable Viscosupplementation for Joint Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Injectable Viscosupplementation for Joint Sales Forecast by Country (2024-2029) & (Units)
Table 68. Americas Injectable Viscosupplementation for Joint Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Injectable Viscosupplementation for Joint Sales Forecast by Region (2024-2029) & (Units)
Table 70. APAC Injectable Viscosupplementation for Joint Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Injectable Viscosupplementation for Joint Sales Forecast by Country (2024-2029) & (Units)
Table 72. Europe Injectable Viscosupplementation for Joint Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Injectable Viscosupplementation for Joint Sales Forecast by Country (2024-2029) & (Units)
Table 74. Middle East & Africa Injectable Viscosupplementation for Joint Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Injectable Viscosupplementation for Joint Sales Forecast by Type (2024-2029) & (Units)
Table 76. Global Injectable Viscosupplementation for Joint Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Injectable Viscosupplementation for Joint Sales Forecast by Application (2024-2029) & (Units)
Table 78. Global Injectable Viscosupplementation for Joint Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Sanofi Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 81. Sanofi Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Anika Therapeutics Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 85. Anika Therapeutics Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 86. Anika Therapeutics Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Anika Therapeutics Main Business
Table 88. Anika Therapeutics Latest Developments
Table 89. Seikagaku Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 90. Seikagaku Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 91. Seikagaku Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Seikagaku Main Business
Table 93. Seikagaku Latest Developments
Table 94. Zimmer Biomet Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 95. Zimmer Biomet Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 96. Zimmer Biomet Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Zimmer Biomet Main Business
Table 98. Zimmer Biomet Latest Developments
Table 99. Bioventus Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 100. Bioventus Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 101. Bioventus Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Bioventus Main Business
Table 103. Bioventus Latest Developments
Table 104. Ferring Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 105. Ferring Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 106. Ferring Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Ferring Main Business
Table 108. Ferring Latest Developments
Table 109. LG Chem Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 110. LG Chem Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 111. LG Chem Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. LG Chem Main Business
Table 113. LG Chem Latest Developments
Table 114. Freda Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 115. Freda Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 116. Freda Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Freda Main Business
Table 118. Freda Latest Developments
Table 119. Haohai Biological Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 120. Haohai Biological Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 121. Haohai Biological Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Haohai Biological Main Business
Table 123. Haohai Biological Latest Developments
Table 124. Shanghai Jingfeng Basic Information, Injectable Viscosupplementation for Joint Manufacturing Base, Sales Area and Its Competitors
Table 125. Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Portfolios and Specifications
Table 126. Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Shanghai Jingfeng Main Business
Table 128. Shanghai Jingfeng Latest Developments
LIST OF FIGURES
Figure 1. Picture of Injectable Viscosupplementation for Joint
Figure 2. Injectable Viscosupplementation for Joint Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable Viscosupplementation for Joint Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Injectable Viscosupplementation for Joint Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Injectable Viscosupplementation for Joint Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Injection
Figure 10. Product Picture of Three Injection
Figure 11. Product Picture of Five Injection
Figure 12. Global Injectable Viscosupplementation for Joint Sales Market Share by Type in 2022
Figure 13. Global Injectable Viscosupplementation for Joint Revenue Market Share by Type (2018-2023)
Figure 14. Injectable Viscosupplementation for Joint Consumed in Hospital
Figure 15. Global Injectable Viscosupplementation for Joint Market: Hospital (2018-2023) & (Units)
Figure 16. Injectable Viscosupplementation for Joint Consumed in Clinic
Figure 17. Global Injectable Viscosupplementation for Joint Market: Clinic (2018-2023) & (Units)
Figure 18. Injectable Viscosupplementation for Joint Consumed in Other
Figure 19. Global Injectable Viscosupplementation for Joint Market: Other (2018-2023) & (Units)
Figure 20. Global Injectable Viscosupplementation for Joint Sales Market Share by Application (2022)
Figure 21. Global Injectable Viscosupplementation for Joint Revenue Market Share by Application in 2022
Figure 22. Injectable Viscosupplementation for Joint Sales Market by Company in 2022 (Units)
Figure 23. Global Injectable Viscosupplementation for Joint Sales Market Share by Company in 2022
Figure 24. Injectable Viscosupplementation for Joint Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Injectable Viscosupplementation for Joint Revenue Market Share by Company in 2022
Figure 26. Global Injectable Viscosupplementation for Joint Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Injectable Viscosupplementation for Joint Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Injectable Viscosupplementation for Joint Sales 2018-2023 (Units)
Figure 29. Americas Injectable Viscosupplementation for Joint Revenue 2018-2023 ($ Millions)
Figure 30. APAC Injectable Viscosupplementation for Joint Sales 2018-2023 (Units)
Figure 31. APAC Injectable Viscosupplementation for Joint Revenue 2018-2023 ($ Millions)
Figure 32. Europe Injectable Viscosupplementation for Joint Sales 2018-2023 (Units)
Figure 33. Europe Injectable Viscosupplementation for Joint Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Injectable Viscosupplementation for Joint Sales 2018-2023 (Units)
Figure 35. Middle East & Africa Injectable Viscosupplementation for Joint Revenue 2018-2023 ($ Millions)
Figure 36. Americas Injectable Viscosupplementation for Joint Sales Market Share by Country in 2022
Figure 37. Americas Injectable Viscosupplementation for Joint Revenue Market Share by Country in 2022
Figure 38. Americas Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Figure 39. Americas Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Figure 40. United States Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Injectable Viscosupplementation for Joint Sales Market Share by Region in 2022
Figure 45. APAC Injectable Viscosupplementation for Joint Revenue Market Share by Regions in 2022
Figure 46. APAC Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Figure 47. APAC Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Figure 48. China Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Injectable Viscosupplementation for Joint Sales Market Share by Country in 2022
Figure 56. Europe Injectable Viscosupplementation for Joint Revenue Market Share by Country in 2022
Figure 57. Europe Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Figure 58. Europe Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Figure 59. Germany Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Injectable Viscosupplementation for Joint Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Figure 68. Egypt Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Injectable Viscosupplementation for Joint in 2022
Figure 74. Manufacturing Process Analysis of Injectable Viscosupplementation for Joint
Figure 75. Industry Chain Structure of Injectable Viscosupplementation for Joint
Figure 76. Channels of Distribution
Figure 77. Global Injectable Viscosupplementation for Joint Sales Market Forecast by Region (2024-2029)
Figure 78. Global Injectable Viscosupplementation for Joint Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Injectable Viscosupplementation for Joint Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Injectable Viscosupplementation for Joint Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Injectable Viscosupplementation for Joint Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Injectable Viscosupplementation for Joint Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Injectable Viscosupplementation for Joint
Figure 2. Injectable Viscosupplementation for Joint Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable Viscosupplementation for Joint Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Injectable Viscosupplementation for Joint Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Injectable Viscosupplementation for Joint Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Injection
Figure 10. Product Picture of Three Injection
Figure 11. Product Picture of Five Injection
Figure 12. Global Injectable Viscosupplementation for Joint Sales Market Share by Type in 2022
Figure 13. Global Injectable Viscosupplementation for Joint Revenue Market Share by Type (2018-2023)
Figure 14. Injectable Viscosupplementation for Joint Consumed in Hospital
Figure 15. Global Injectable Viscosupplementation for Joint Market: Hospital (2018-2023) & (Units)
Figure 16. Injectable Viscosupplementation for Joint Consumed in Clinic
Figure 17. Global Injectable Viscosupplementation for Joint Market: Clinic (2018-2023) & (Units)
Figure 18. Injectable Viscosupplementation for Joint Consumed in Other
Figure 19. Global Injectable Viscosupplementation for Joint Market: Other (2018-2023) & (Units)
Figure 20. Global Injectable Viscosupplementation for Joint Sales Market Share by Application (2022)
Figure 21. Global Injectable Viscosupplementation for Joint Revenue Market Share by Application in 2022
Figure 22. Injectable Viscosupplementation for Joint Sales Market by Company in 2022 (Units)
Figure 23. Global Injectable Viscosupplementation for Joint Sales Market Share by Company in 2022
Figure 24. Injectable Viscosupplementation for Joint Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Injectable Viscosupplementation for Joint Revenue Market Share by Company in 2022
Figure 26. Global Injectable Viscosupplementation for Joint Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Injectable Viscosupplementation for Joint Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Injectable Viscosupplementation for Joint Sales 2018-2023 (Units)
Figure 29. Americas Injectable Viscosupplementation for Joint Revenue 2018-2023 ($ Millions)
Figure 30. APAC Injectable Viscosupplementation for Joint Sales 2018-2023 (Units)
Figure 31. APAC Injectable Viscosupplementation for Joint Revenue 2018-2023 ($ Millions)
Figure 32. Europe Injectable Viscosupplementation for Joint Sales 2018-2023 (Units)
Figure 33. Europe Injectable Viscosupplementation for Joint Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Injectable Viscosupplementation for Joint Sales 2018-2023 (Units)
Figure 35. Middle East & Africa Injectable Viscosupplementation for Joint Revenue 2018-2023 ($ Millions)
Figure 36. Americas Injectable Viscosupplementation for Joint Sales Market Share by Country in 2022
Figure 37. Americas Injectable Viscosupplementation for Joint Revenue Market Share by Country in 2022
Figure 38. Americas Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Figure 39. Americas Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Figure 40. United States Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Injectable Viscosupplementation for Joint Sales Market Share by Region in 2022
Figure 45. APAC Injectable Viscosupplementation for Joint Revenue Market Share by Regions in 2022
Figure 46. APAC Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Figure 47. APAC Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Figure 48. China Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Injectable Viscosupplementation for Joint Sales Market Share by Country in 2022
Figure 56. Europe Injectable Viscosupplementation for Joint Revenue Market Share by Country in 2022
Figure 57. Europe Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Figure 58. Europe Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Figure 59. Germany Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Injectable Viscosupplementation for Joint Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Application (2018-2023)
Figure 68. Egypt Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Injectable Viscosupplementation for Joint Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Injectable Viscosupplementation for Joint in 2022
Figure 74. Manufacturing Process Analysis of Injectable Viscosupplementation for Joint
Figure 75. Industry Chain Structure of Injectable Viscosupplementation for Joint
Figure 76. Channels of Distribution
Figure 77. Global Injectable Viscosupplementation for Joint Sales Market Forecast by Region (2024-2029)
Figure 78. Global Injectable Viscosupplementation for Joint Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Injectable Viscosupplementation for Joint Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Injectable Viscosupplementation for Joint Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Injectable Viscosupplementation for Joint Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Injectable Viscosupplementation for Joint Revenue Market Share Forecast by Application (2024-2029)
